1-[5-Methoxy-6-(4-methyl-piperazin-1-yl)-2,3-dihydro-indol-1-yl]-2-(4-nitro-phenyl)-ethanone

ID: ALA2113097

Chembl Id: CHEMBL2113097

PubChem CID: 71458050

Max Phase: Preclinical

Molecular Formula: C22H26N4O4

Molecular Weight: 410.47

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc2c(cc1N1CCN(C)CC1)N(C(=O)Cc1cccc([N+](=O)[O-])c1)CC2

Standard InChI:  InChI=1S/C22H26N4O4/c1-23-8-10-24(11-9-23)20-15-19-17(14-21(20)30-2)6-7-25(19)22(27)13-16-4-3-5-18(12-16)26(28)29/h3-5,12,14-15H,6-11,13H2,1-2H3

Standard InChI Key:  KQAZXGGJWOJJAY-UHFFFAOYSA-N

Associated Targets(Human)

HTR1A Tclin Serotonin 1a (5-HT1a) receptor (14969 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR1B Tclin Serotonin 1b (5-HT1b) receptor (2801 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR1D Tclin Serotonin 1d (5-HT1d) receptor (2897 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR1B Tclin Serotonin 1 receptors; 5-HT1B & 5-HT1D (345 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 410.47Molecular Weight (Monoisotopic): 410.1954AlogP: 2.49#Rotatable Bonds: 5
Polar Surface Area: 79.16Molecular Species: NEUTRALHBA: 6HBD:
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.41CX LogP: 2.69CX LogD: 2.38
Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.56Np Likeness Score: -1.48

References

1. Wyman PA, Marshall HR, Flynn ST, King RJ, Thompson M, Smith PW, Hadley MS, Price GW, Scott CM, Dawson LA..  (2005)  Identification of a potent and selective 5-HT1B receptor antagonist.,  15  (21): [PMID:16153839] [10.1016/j.bmcl.2005.07.085]

Source